Growing up, many of us have used products by Johnson & Johnson. ‘J&J’ is an American company which produces, among other things, no-tears baby shampoo, the Janssen COVID vaccine, mouthwash, and the most popular branded paracetamol product in the US. J&J’s consumer health is usually seen as the ‘face’ of the company, with brands like Band-Aid and Tylenol being long-standing household names, but its revenues are dwarfed by the pharmaceutical segment. Overall, J&J is the largest pharmaceutical company in the world.
The company was founded in 1886 in New Brunswick, New Jersey under ‘Johnson & Johnson’ by brothers Robert, James, and Edward Johnson, who began producing medicated plasters. J&J grew steadily, and it expanded into Canada in 1919 and then Britain in 1924. Among other popular innovations, the company created and popularized the ‘first-aid kit’, which was supplied to workers far away from hospitals. Their reputation for innovation continued with the launch of the famous ‘no more tears’ baby shampoo in 1953 and continued throughout the rest of the century, developing the first coronary stent in 1994. Anti-cancer drugs are some of J&J’s biggest sellers, alongside the immunology division. Within the immunology department, the monoclonal antibody treatment Ustekinumab is the company’s biggest source of revenue, and it made $6.3 billion in sales in 2019 alone.
In 2021, recognizing the disparate nature of its product portfolio, CEO Alex Gorsky announced the company’s intention to separate consumer products and pharmaceutical businesses. The latter division sometimes operates under the name Janssen, and it will retain the J&J name and ticker. In the same year, J&J saw disappointing sales of its Janssen COVID vaccine. Though it remains a highly profitable product, it was relegated to a secondary option or given away by certain countries.
J&J began listing on the New York Stock Exchange in 1944 at $37.50 per share under the ticker ‘JNJ’. As of 2021, it has a market capitalization of $428.82 billion. J&J is a constituent stock of the Dow Jones Industrial Average and the S&P500 and accordingly is very popular with institutional investors, with Vanguard and State Street being the largest shareholders.
Buy Johnson & Johnson shares by logging in on one of our platforms - SaxoInvestor, SaxoTraderGO or SaxoTraderPRO - and search for the ticker ‘JNJ’. If you don’t have an account, you can create one by clicking here.
Find the live price for Johnson & Johnson shares by logging in to your account and searching for Johnson & Johnson. Then, select the trade ticket, click on the ‘I’ icon and then navigate to ‘Trading Rates’ to see transaction costs. New customers of Saxo can click here to open an account now.
On our platforms we offer plenty of different financial information to help you decide if Johnson & Johnson is the right investment for you. You will find stock analysis, financial reports, and current and historical price charts on your account. You can open an account here.
Johnson & Johnson has consistently paid and increased its quarterly dividend for many years. However, dividends always remain discretionary and are never guaranteed. Find Johnson & Johnson dividend history and yield by logging in to your account. If you don't have one yet, you can create one here.
You can check how Johnson & Johnson shares have performed in the past by logging in to your trading platform account to see price charts and historical financial data. If you don’t have an account with Saxo, you can open one by clicking here.
